Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

HOLX

Hologic, Inc

Feb 13 • 04:00PM ET

75.04

+0.13 0.17 %

Healthcare • Medical Instruments & Supplies • USA • NASD

Peers: ABT BDX MDT QGEN ILMN BIO DGX A RMD

| Held by: VTI VOO VB VBR IVV SPY RSP XLV IHI IWR

Index	S&P 500	P/E	31.14	EPS (ttm)	2.41	Insider Own	1.51%	Shs Outstand	223.07M	Perf Week	0.31%
Market Cap	16.75B	Forward P/E	15.42	EPS next Y	4.87	Insider Trans	-4.14%	Shs Float	219.86M	Perf Month	-0.16%
Enterprise Value	16.91B	PEG	2.15	EPS next Q	1.07	Inst Own	94.12%	Short Float	1.89%	Perf Quarter	0.64%
Income	543.90M	P/S	4.06	EPS this Y	4.47%	Inst Trans	-4.11%	Short Ratio	1.48	Perf Half Y	10.26%
Sales	4.13B	P/B	3.19	EPS next Y	9.36%	ROA	6.07%	Short Interest	4.15M	Perf YTD	0.74%
Book/sh	23.51	P/C	7.08	EPS next 5Y	7.16%	ROE	10.86%	52W High	75.36 -0.42%	Perf Year	17.95%
Cash/sh	10.59	P/FCF	17.50	EPS past 3/5Y	-21.45% -10.02%	ROIC	7.01%	52W Low	51.90 44.59%	Perf 3Y	-10.09%
Dividend Est.	-	EV/EBITDA	13.40	Sales past 3/5Y	-5.53% 1.66%	Gross Margin	55.62%	Volatility	0.28% 0.32%	Perf 5Y	-9.57%
Dividend TTM	-	EV/Sales	4.10	EPS Y/Y TTM	-23.89%	Oper. Margin	23.66%	ATR (14)	0.26	Perf 10Y	130.18%
Dividend Ex-Date	-	Quick Ratio	3.32	Sales Y/Y TTM	2.17%	Profit Margin	13.18%	RSI (14)	54.78	Recom	3.06
Dividend Gr. 3/5Y	- -	Current Ratio	4.04	EPS Q/Q	-8.44%	SMA20	0.09%	Beta	0.73	Target Price	76.57
Payout	0.00%	Debt/Eq	0.48	Sales Q/Q	2.54%	SMA50	0.19%	Rel Volume	0.82	Prev Close	74.91
Employees	7070	LT Debt/Eq	0.48	Earnings	Jan 29 AMC	SMA200	9.43%	Avg Volume	2.80M	Price	75.04
IPO	Mar 01, 1990	Option/Short	Yes / Yes	EPS/Sales Surpr.	-5.08% -2.20%	Trades		Volume	2,282,627	Change	0.17%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-12-26	Downgrade	Argus	Buy → Hold
Jan-05-26	Downgrade	Evercore ISI	Outperform → In-line	$78
Nov-21-25	Downgrade	BNP Paribas Exane	Outperform → Neutral	$79
Oct-07-25	Upgrade	Evercore ISI	In-line → Outperform	$78
Aug-18-25	Upgrade	Argus	Hold → Buy	$80
Aug-06-25	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$87
Jul-09-25	Upgrade	Citigroup	Neutral → Buy	$80
May-27-25	Reiterated	Needham	Hold
Mar-03-25	Downgrade	Argus	Buy → Hold
Feb-06-25	Downgrade	Leerink Partners	Outperform → Market Perform	$80 → $75
Feb-03-25	Downgrade	Needham	Buy → Hold
Dec-13-24	Initiated	Wolfe Research	Peer Perform
Dec-10-24	Reiterated	Needham	Buy	$90
Dec-10-24	Initiated	Jefferies	Hold	$85
Oct-01-24	Downgrade	Citigroup	Buy → Neutral	$95 → $85
Jun-27-24	Initiated	Stephens	Overweight	$87
Apr-03-24	Upgrade	Citigroup	Neutral → Buy	$80 → $95
Jul-14-23	Upgrade	Needham	Hold → Buy	$95
Dec-07-22	Initiated	RBC Capital Mkts	Sector Perform	$75
Oct-13-22	Initiated	Mizuho	Buy	$75

Show Previous Ratings

Today 09:42AM	How to Play Hologic Stock Post Q1 Earnings and Progress on Buyout? (Zacks)
Feb-13-26 09:00AM	Is Most-Watched Stock Hologic, Inc. (HOLX) Worth Betting on Now? (Zacks)
Feb-10-26 08:57AM	Is Wall Street Bullish or Bearish on Hologic Stock? (Barchart)
Feb-06-26 11:45AM	Analyst Report: Hologic, Inc. (Morningstar Research)
Feb-04-26 08:15AM	Hologic Receives FDA Approval for Aptima HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio (Business Wire)
01:02PM	Loading…
Feb-03-26 01:02PM	Robert Olstein's Strategic Moves: Exiting Hologic Inc with a -1.44% Impact (GuruFocus.com)
Feb-02-26 09:15AM	Hologic (HOLX) International Revenue Performance Explored (Zacks)
09:00AM	Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Jan-30-26 08:28AM	HOLX Stock Slips on Q1 Earnings and Revenue Miss, Margins Crash (Zacks)
Jan-29-26 08:42PM	Blackstone Q4 Earnings Call Highlights (MarketBeat)
06:00PM	Compared to Estimates, Hologic (HOLX) Q1 Earnings: A Look at Key Metrics (Zacks)
05:25PM	Hologic (HOLX) Misses Q1 Earnings and Revenue Estimates (Zacks)
04:19PM	Hologic: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:11PM	Hologic (NASDAQ:HOLX) Misses Q4 CY2025 Revenue Estimates (StockStory)
04:02PM	Hologic Announces Financial Results for First Quarter of Fiscal 2026 (Business Wire)
12:51PM	Loading…
12:51PM	Will Revvity Q4 Earnings Benefit From Early Signs of Demand Recovery? (Zacks)
Jan-28-26 08:24AM	SYK's Q4 Results Likely to Reflect Procedure Growth and Capital Demand (Zacks)
06:46AM	Medtech M&A took off in the second half of 2025: report (MedTech Dive)
Jan-27-26 10:10PM	Hologic (HOLX) Q4 Earnings: What To Expect (StockStory)
Jan-26-26 09:15AM	Stay Ahead of the Game With Hologic (HOLX) Q1 Earnings: Wall Street's Insights on Key Metrics (Zacks)
Jan-23-26 04:20PM	Analysts consider potential Qiagen deal amid reported strategic review (Investing.com)
08:48AM	Danaher Gears Up to Post Q4 Earnings: What Lies Ahead for the Stock? (Zacks)
Jan-22-26 10:00AM	Hologic (HOLX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
08:55AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
08:50AM	Hologic Q1 Earnings Preview: How Should You Play the Stock Now? (Zacks)
Jan-21-26 12:10PM	Will Hologic (HOLX) Beat Estimates Again in Its Next Earnings Report? (Zacks)
09:50AM	Here's Why Hologic (HOLX) is a Strong Momentum Stock (Zacks)
08:55AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
07:51AM	Will GYN Surgical Power Hologic's Growth in the Upcoming Q1 Earnings? (Zacks)
Jan-20-26 11:34PM	Analyst Report: Hologic, Inc. (Morningstar Research)
06:02PM	Loading…
Jan-19-26 06:02PM	Hologic, Inc. (HOLX): A Bear Case Theory (Insider Monkey)
07:52AM	HOLX vs. SYK: Which Medical Device Leader Is a Solid Bet Now? (Zacks)
Jan-16-26 11:56AM	Bedside Breakthrough: AI Brings MRI-Precision to Every Clinic (PR Newswire)
09:00AM	Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
07:18AM	Hologic Leads Campaign to Emphasize Routine Cervical Cancer Screening (Zacks)
Jan-15-26 11:37PM	1 Healthcare Stock Worth Investigating and 2 That Underwhelm (StockStory)
Jan-13-26 09:00AM	Professional Basketball Player Erica Wheeler and Hologic Team Up to Champion Cervical Cancer Screening (Business Wire)
Jan-10-26 03:00PM	More Bonds Are Teetering on the Brink of Junk: Credit Weekly (Bloomberg)
Jan-09-26 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Jan-08-26 11:51AM	Halper Sadeh LLC Encourages HOLX, VTYX, QRVO, TEX Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
11:40AM	HOLX vs. SONVY: Which Stock Should Value Investors Buy Now? (Zacks)
06:44AM	What You Need To Know Ahead of Hologic's Earnings Release (Barchart)
Jan-07-26 11:40AM	HOLX or SONVY: Which Is the Better Value Stock Right Now? (Zacks)
Jan-06-26 11:40AM	HOLX vs. SONVY: Which Stock Is the Better Value Option? (Zacks)
08:17AM	Hologic's Breast Health Unit Stays In Focus in 2026: What Lies Ahead? (Zacks)
Jan-05-26 07:17AM	Hologic Trading Near 52-Week High: How Should You Play the Stock? (Zacks)
Dec-31-25 08:55AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
07:25AM	Smart Oncology: 5 Stocks Chasing the $317B Prize (PR Newswire)
Dec-26-25 07:53AM	Hologic's GYN Surgical Segment Looks Poised for Long-Term Growth (Zacks)
Dec-24-25 10:31PM	Spotting Winners: Hologic (NASDAQ:HOLX) And Medical Devices & Supplies - Imaging, Diagnostics Stocks In Q3 (StockStory)
Dec-23-25 06:56PM	Halper Sadeh LLC Encourages SNCR, HOLX, FRGE Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
09:00AM	Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock (Zacks)
Dec-22-25 07:58AM	HOLX vs. LH: Which MedTech Stock Is the Stronger Investment Now? (Zacks)
Dec-18-25 09:40AM	Why This 1 Value Stock Could Be a Great Addition to Your Portfolio (Zacks)
Dec-17-25 12:01PM	HOLX's Genius AI Mammography Flags Missed Breast Cancer Cases (Zacks)
09:50AM	Why Hologic (HOLX) is a Top Momentum Stock for the Long-Term (Zacks)
08:26AM	Hologic's Genius AI Detection Shows Value by Spotting Missed Cancers (Zacks)
Dec-12-25 09:00AM	Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
07:34AM	What Is Driving Hologic's Strength in the US Diagnostics Market? (Zacks)
04:04AM	Is Hologic Stock Outperforming the Nasdaq? (Barchart)
Dec-11-25 08:54PM	Halper Sadeh LLC Encourages DHIL, SNCR, FRGE, HOLX Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
Dec-08-25 09:19AM	HOLX Stock Up 16% in 6 Months: Is it Still a Hold Heading Into 2026? (Zacks)
Dec-07-25 11:37PM	1 Mooning Stock on Our Watchlist and 2 Facing Headwinds (StockStory)
Dec-06-25 01:25PM	US Loses Financing Edge as Asia Borrows in Euros: Credit Weekly (Bloomberg)
Dec-04-25 10:23AM	Hologic's BCI Test Shows Growing Impact in Endocrine Therapy Decisions (Zacks)
Dec-03-25 12:45PM	Cooper Companies to Post Q4 Earnings: What's in Store for the Stock? (Zacks)
11:30AM	Why Is Hologic (HOLX) Up 1% Since Last Earnings Report? (Zacks)
Dec-02-25 08:10AM	New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test, the Leading Biomarker in Personalizing Endocrine Therapy Duration (Business Wire)
Dec-01-25 09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
09:00AM	Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Nov-27-25 08:23AM	HOLX vs. DGX: Which Healthcare Diagnostics Stock Is the Better Bet? (Zacks)
Nov-26-25 09:40AM	Here's Why Hologic (HOLX) is a Strong Value Stock (Zacks)
08:18AM	New Clinical Evidence Bolsters Hologic's Breast Cancer Technologies (Zacks)
Nov-25-25 08:08AM	New Clinical Evidence on Hologics AI-Powered Mammography Solutions Will Be Unveiled at RSNA (Business Wire)
Nov-21-25 09:10AM	Here Are Fridays Top Wall Street Analysts Research Calls: Advanced Micro Devices, Block, Broadcom, Exact Sciences, Hologic, Palo Alto Networks and More (24/7 Wall St.)
07:13AM	Hologic's GYN Surgical Delivers a Standout Quarter: What's Behind It? (Zacks)
Nov-20-25 09:31AM	US healthcare group Abbott bets on cancer screening technology in $23bn deal (Financial Times)
Nov-19-25 11:02PM	3 Reasons HOLX is Risky and 1 Stock to Buy Instead (StockStory)
Nov-18-25 09:29AM	Should You Continue to Hold Hologic Stock Post Q4 Earnings? (Zacks)
09:00AM	Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know (Zacks)
Nov-14-25 04:01PM	VolitionRX Ltd (VNRX) Q3 2025 Earnings Call Highlights: Strategic Partnerships and Revenue ... (GuruFocus.com)
03:19PM	Halper Sadeh LLC Encourages CDTX, MRSN, HOLX Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
Nov-13-25 08:49AM	Hologic Expands European Reach of Genius Digital Diagnostics System (Zacks)
Nov-12-25 09:50AM	Here's Why Hologic (HOLX) is a Strong Momentum Stock (Zacks)
08:11AM	Hologic Introduces Digital Pathology Capabilities With Expanded CE Marking (Business Wire)
Nov-11-25 11:41AM	The transatlantic medtech investment gap: why does it exist and can it be plugged? (Medical Device Network)
Nov-10-25 09:40AM	Why Hologic (HOLX) is a Top Value Stock for the Long-Term (Zacks)
Nov-07-25 04:36PM	Halper Sadeh LLC Encourages IMXI, CMA, HOLX Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
09:00AM	Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock (Zacks)
07:37AM	Hologic's Breast Health Rebounds, Takes Spotlight in Buyout Deal (Zacks)
Nov-04-25 08:07AM	HOLX Stock Up on Q4 Earnings & Revenue Beat, Operating Margin Expands (Zacks)
Nov-03-25 06:45PM	Analyst Report: Hologic, Inc. (Morningstar Research)
05:30PM	Hologic (HOLX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:15PM	Hologic (HOLX) Q4 Earnings and Revenues Beat Estimates (Zacks)
04:28PM	Hologic (NASDAQ:HOLX) Exceeds Q3 Expectations (StockStory)
04:22PM	Hologic: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	Hologic Announces Financial Results for Fourth Quarter of Fiscal 2025 (Business Wire)
Nov-01-25 11:06PM	Hologic (HOLX) Reports Q3: Everything You Need To Know Ahead Of Earnings (StockStory)
Oct-30-25 12:25PM	Halper Sadeh LLC Encourages HOLX, FITB, HSII Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
09:06AM	HOLX vs. ABT: Which Medical Technology Stock Is the Better Investment? (Zacks)

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focus on women's health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology, and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Stamoulis Christiana	Director	Oct 20 '25	Option Exercise	36.04	7,402	266,768	54,738	Oct 22 04:17 PM
Stamoulis Christiana	Director	Oct 20 '25	Sale	73.07	7,402	540,864	47,336	Oct 22 04:17 PM
Stamoulis Christiana	Director	Oct 20 '25	Proposed Sale	73.07	7,402	540,864		Oct 20 10:12 AM
MACMILLAN STEPHEN P	Chairman, President and CEO	Sep 22 '25	Option Exercise	39.96	138,358	5,528,786	1,372,982	Sep 23 04:10 PM
MACMILLAN STEPHEN P	Chairman, President and CEO	Sep 22 '25	Sale	66.97	138,358	9,266,118	1,234,624	Sep 23 04:10 PM
MACMILLAN STEPHEN P	Officer	Sep 22 '25	Proposed Sale	66.98	138,358	9,266,548		Sep 22 04:25 PM
Madaus Martin D	Director	May 07 '25	Buy	55.24	5,445	300,760	5,445	May 09 04:39 PM

Open in Screener

AZTA

Azenta Inc

Feb 13 • 04:00PM ET

28.62

+0.50 1.78 %

Healthcare • Medical Instruments & Supplies • USA • NASD

Peers: DHR ILMN TMO A BIO HOLX WAT CTLT QGEN MMS

| Held by: IJR VTI VB IWM VBR VXF SPSM IWN VTWO DFSV

Index	RUT	P/E	-	EPS (ttm)	-1.27	Insider Own	1.09%	Shs Outstand	46.02M	Perf Week	-0.35%
Market Cap	1.32B	Forward P/E	27.41	EPS next Y	1.04	Insider Trans	-0.06%	Shs Float	45.56M	Perf Month	-27.54%
Enterprise Value	960.65M	PEG	0.77	EPS next Q	0.12	Inst Own	111.02%	Short Float	9.18%	Perf Quarter	-6.99%
Income	-57.82M	P/S	2.21	EPS this Y	54.90%	Inst Trans	-1.36%	Short Ratio	5.39	Perf Half Y	-6.44%
Sales	595.19M	P/B	0.77	EPS next Y	32.19%	ROA	1.41%	Short Interest	4.18M	Perf YTD	-13.95%
Book/sh	37.26	P/C	3.20	EPS next 5Y	35.42%	ROE	1.69%	52W High	47.55 -39.81%	Perf Year	-36.55%
Cash/sh	8.95	P/FCF	42.62	EPS past 3/5Y	40.29% -	ROIC	-3.27%	52W Low	23.91 19.70%	Perf 3Y	-36.53%
Dividend Est.	-	EV/EBITDA	19.60	Sales past 3/5Y	2.25% 8.85%	Gross Margin	45.30%	Volatility	6.37% 5.56%	Perf 5Y	-68.53%
Dividend TTM	-	EV/Sales	1.61	EPS Y/Y TTM	57.71%	Oper. Margin	-1.30%	ATR (14)	1.99	Perf 10Y	235.52%
Dividend Ex-Date	Dec 02, 2021	Quick Ratio	2.61	Sales Y/Y TTM	-8.36%	Profit Margin	-9.71%	RSI (14)	30.56	Recom	2.12
Dividend Gr. 3/5Y	- -	Current Ratio	2.92	EPS Q/Q	-14.91%	SMA20	-18.73%	Beta	1.39	Target Price	37.71
Payout	-	Debt/Eq	0.03	Sales Q/Q	0.77%	SMA50	-19.52%	Rel Volume	1.03	Prev Close	28.12
Employees	3000	LT Debt/Eq	0.03	Earnings	Feb 04 BMO	SMA200	-9.76%	Avg Volume	775.79K	Price	28.62
IPO	Feb 02, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	-34.83% 1.06%	Trades		Volume	800,282	Change	1.78%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-05-26	Upgrade	Evercore ISI	In-line → Outperform	$50
Dec-19-25	Reiterated	Needham	Buy	$42 → $44
Oct-30-25	Upgrade	Jefferies	Hold → Buy	$38
Aug-06-25	Upgrade	Raymond James	Mkt Perform → Outperform	$35
Jul-22-25	Resumed	Stephens	Equal-Weight	$35
Dec-18-24	Upgrade	Stephens	Equal-Weight → Overweight	$50 → $60
Apr-04-24	Initiated	Jefferies	Hold	$64
Feb-01-24	Reiterated	B. Riley Securities	Buy	$61 → $79
Jul-19-23	Initiated	Raymond James	Mkt Perform
May-10-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Feb-09-23	Downgrade	Stephens	Overweight → Equal-Weight	$65 → $60
Jan-03-23	Downgrade	Evercore ISI	Outperform → In-line	$60 → $62
Mar-31-22	Resumed	B. Riley Securities	Buy	$106
Mar-21-22	Initiated	Evercore ISI	Outperform	$100

Show Previous Ratings

Feb-13-26 09:33AM	Should You Buy, Hold or Sell Tempus AI Stock Pre-Q4 Earnings Release? (Zacks)
Feb-11-26 12:36AM	The Top 5 Analyst Questions From Azenta's Q4 Earnings Call (StockStory)
Feb-09-26 04:05PM	Azenta Life Sciences and Frontier Space Announce Strategic Partnership to Advance Space-Based Life Sciences Research Infrastructure (PR Newswire)
Feb-05-26 08:00AM	Stocks making big moves yesterday: Azenta, FTAI Aviation, Reddit, Columbia Sportswear, and RenaissanceRe (StockStory)
12:33AM	AZTA Q4 Deep Dive: Operational Challenges and Turnaround Efforts Dominate Results (StockStory)
04:03PM	Loading…
Feb-04-26 04:03PM	Azenta Inc (AZTA) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic Focus ... (GuruFocus.com) -22.81%
12:25PM	Azenta (AZTA) Stock Trades Down, Here Is Why (StockStory)
10:10AM	Azenta Q1 Earnings Call Highlights (MarketBeat)
09:59AM	Azenta (AZTA) Q1 2026 Earnings Call Transcript (Motley Fool)
08:12AM	Azenta's (NASDAQ:AZTA) Q4 CY2025: Beats On Revenue (StockStory)
06:30AM	Azenta Reports First Quarter Results for Fiscal 2026, Ended December 31, 2025 (PR Newswire)
Feb-02-26 10:17PM	Azenta (AZTA) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Jan-21-26 04:05PM	Azenta Announces Fiscal 2026 First Quarter Conference Call and Webcast (PR Newswire)
Jan-08-26 04:48AM	New Strong Sell Stocks for January 8th (Zacks)
Jan-05-26 03:45PM	Why Are Azenta (AZTA) Shares Soaring Today (StockStory) +7.07%
09:01AM	Loading…
Dec-31-25 09:01AM	Vale and Azenta have been highlighted as Zacks Bull and Bear of the Day (Zacks)
04:00AM	Bear of the Day: Azenta (AZTA) (Zacks)
Dec-30-25 08:05AM	Azenta enters agreement for sale of B Medical Systems to THELEMA for $63M (TipRanks)
03:12AM	New Strong Sell Stocks for December 30th (Zacks)
Dec-29-25 08:00AM	Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.A R.L. (PR Newswire)
Dec-28-25 11:02PM	Azenta (AZTA): Buy, Sell, or Hold Post Q3 Earnings? (StockStory)
Dec-15-25 05:46AM	New Strong Sell Stocks for Dec. 15 (Zacks)
Dec-10-25 12:43PM	Azenta Authorizes $250 Million Share Repurchase Program (PR Newswire)
Dec-09-25 05:51AM	New Strong Sell Stocks for December 9th (Zacks)
Dec-02-25 11:32PM	3 Healthcare Stocks We're Skeptical Of (StockStory)
Nov-27-25 10:32PM	Q3 Rundown: Azenta (NASDAQ:AZTA) Vs Other Drug Development Inputs & Services Stocks (StockStory)
Nov-24-25 01:01PM	Why Azenta (AZTA) Stock Is Trading Up Today (StockStory) +5.19%
Nov-22-25 12:30AM	AZTA Q3 Deep Dive: Operational Discipline and Product Strength Support Margin Expansion (StockStory)
Nov-21-25 05:16PM	Why Azenta (AZTA) Stock Is Up Today (StockStory) +16.30% +5.19%
04:00PM	Azenta Inc (AZTA) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
06:41AM	Loading…
06:41AM	Azenta (NASDAQ:AZTA) Surprises With Q3 CY2025 Sales (StockStory)
06:30AM	Azenta Reports Fourth Quarter and Full Year Fiscal 2025 Results, Ended September 30, 2025 (PR Newswire)
Nov-19-25 10:01PM	Azenta (AZTA) Reports Q3: Everything You Need To Know Ahead Of Earnings (StockStory)
Nov-12-25 04:05PM	Azenta Announces Fiscal 2025 Fourth Quarter and Full Year Conference Call and Webcast (PR Newswire)
Nov-10-25 05:20PM	Outset Medical, Inc. (OM) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
Nov-06-25 06:05PM	TruBridge (TBRG) Q3 Earnings and Revenues Surpass Estimates (Zacks)
Nov-05-25 07:05PM	Senseonics Holdings (SENS) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
Nov-04-25 04:05PM	Azenta Life Sciences Partners with PRECEDE Foundation to Advance Early Detection of Pancreatic Cancer (PR Newswire)
Oct-15-25 08:00AM	Azenta to Host Investor Day at its Biorepository Facility in Indianapolis, Indiana (PR Newswire)
Sep-09-25 08:44AM	TEM Q2 Revenues Soar Amid Coverage Issues: Time to Buy, Hold or Sell? (Zacks)
Sep-02-25 08:04AM	Here's What Pressured Azenta (AZTA) in Q2 (Insider Monkey)
Aug-25-25 11:36PM	Spotting Winners: Azenta (NASDAQ:AZTA) And Drug Development Inputs & Services Stocks In Q2 (StockStory)
Aug-21-25 12:02AM	3 Reasons to Avoid AZTA and 1 Stock to Buy Instead (StockStory)
Aug-13-25 05:50PM	Azenta, LifeStance Health Group, BioMarin Pharmaceutical, AMN Healthcare Services, and ANI Pharmaceuticals Stocks Trade Up, What You Need To Know (StockStory) +9.83%
12:13AM	The Top 5 Analyst Questions From Azenta's Q2 Earnings Call (StockStory)
12:11AM	AZTA Q2 Deep Dive: Product Mix Shifts and Cost Controls Define Flat Quarter (StockStory)
Aug-07-25 03:36PM	Why Azenta (AZTA) Stock Is Up Today (StockStory)
Aug-06-25 02:50PM	Azenta (AZTA) Stock Trades Up, Here Is Why (StockStory) +5.58%
Aug-05-25 12:40PM	Why Azenta (AZTA) Stock Is Trading Lower Today (StockStory) -17.00%
07:16AM	Azenta (NASDAQ:AZTA) Misses Q2 Sales Targets (StockStory)
06:30AM	Azenta Reports Third Quarter Results for Fiscal 2025, Ended June 30, 2025; Reiterates Full Year Fiscal 2025 Guidance (PR Newswire)
Aug-03-25 11:10PM	Azenta (AZTA) Q2 Earnings Report Preview: What To Look For (StockStory)
Jul-31-25 04:05PM	Azenta Life Sciences Partners with Frenova, a Division of Fresenius Medical Care, and Nephronomics to Advance Genomic Research in Nephrology (PR Newswire)
08:30AM	Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care (PR Newswire)
Jul-30-25 04:05PM	Azenta to Participate in 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference (PR Newswire)
Jul-23-25 04:05PM	Azenta Announces Fiscal 2025 Third Quarter Earnings Conference Call and Webcast (PR Newswire)
Jul-22-25 02:06PM	Why Azenta (AZTA) Stock Is Up Today (StockStory) +5.11%
Jul-17-25 11:31PM	Winners And Losers Of Q1: Azenta (NASDAQ:AZTA) Vs The Rest Of The Drug Development Inputs & Services Stocks (StockStory)
Jul-16-25 11:33PM	Q1 Earnings Outperformers: Azenta (NASDAQ:AZTA) And The Rest Of The Drug Development Inputs & Services Stocks (StockStory)
Jun-02-25 12:02AM	3 Reasons to Sell AZTA and 1 Stock to Buy Instead (StockStory)
May-13-25 04:05PM	Azenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy Development (PR Newswire)
May-08-25 03:11AM	Azenta Inc (AZTA) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Macroeconomic ... (GuruFocus.com) +9.70%
May-07-25 01:45PM	Azenta targets 3%-5% organic growth and expands automation initiatives for FY2025 (Seeking Alpha)
01:44PM	Azenta, Inc. (AZTA) Q2 2025 Earnings Call Transcript (Seeking Alpha)
09:35AM	Netflix Investors Unfazed by Tariffs With Growth Engine Humming (Bloomberg)
06:30AM	Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025 (PR Newswire)
Apr-29-25 09:01AM	2 Cash-Heavy Stocks Worth Your Attention and 1 to Approach with Caution (StockStory)
Apr-24-25 04:15PM	Azenta Announces Fiscal 2025 Second Quarter Earnings Conference Call and Webcast (PR Newswire) +5.16%
Apr-17-25 09:31AM	Azenta: Life Science Business Failing To Come To Life (Seeking Alpha)
Mar-27-25 05:13AM	3 Reasons AZTA is Risky and 1 Stock to Buy Instead (StockStory)
Mar-24-25 04:05PM	Azenta Publishes its 2024 Environmental, Social, & Governance (ESG) Report (PR Newswire)
Mar-10-25 05:05PM	Azenta to Participate in the Virtual KeyBanc Capital Markets Healthcare Forum (PR Newswire) -6.62%
Feb-05-25 08:23AM	Azentas (NASDAQ:AZTA) Q4 Sales Top Estimates (StockStory)
07:00AM	Azenta Reports First Quarter Results for Fiscal 2025, Ended December 31, 2024 (PR Newswire)
Feb-04-25 03:59PM	Is Azenta (AZTA) the Mid-Cap Stock Insiders Are Buying Recently? (Insider Monkey)
Jan-30-25 04:05PM	Azenta Announces the Election of Dipal Doshi to its Board of Directors (PR Newswire)
Jan-27-25 04:05PM	Azenta Announces Fiscal 2025 First Quarter Earnings Conference Call and Webcast (PR Newswire)
Jan-23-25 04:05PM	UK Biocentre Selects the Azenta Life Sciences BioArc Ultra Automated Storage System to Advance Research Excellence (PR Newswire)
Nov-29-24 01:00AM	Azenta, Inc. Navigates Global Data Protection Laws Amid Business Risks (TipRanks)
Nov-19-24 05:56PM	Flex Set to Join SandP MidCap 400; Azenta and Concentra Group Holdings to Join SandP SmallCap 600 (PR Newswire) +9.14%
05:56PM	Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600 (PR Newswire)
Nov-14-24 08:00AM	Azenta to Participate in Stephens Annual Investment Conference (PR Newswire)
Nov-13-24 02:17AM	Azenta Inc (AZTA) Q4 2024 Earnings Call Highlights: Navigating Market Challenges with Strategic ... (GuruFocus.com)
Nov-12-24 04:05PM	Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO (PR Newswire)
Nov-04-24 04:05PM	Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and Webcast (PR Newswire) +8.93%
08:00AM	Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive Value (PR Newswire)
Oct-30-24 04:05PM	Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test (PR Newswire)
Sep-04-24 08:00AM	AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO (PR Newswire)
Aug-12-24 04:05PM	GENEWIZ from Azenta Life Sciences Celebrates 25 Years of Advancing Scientific Discoveries at GENEWIZ Week Event (PR Newswire)
Aug-06-24 04:05PM	Azenta Reports Third Quarter Results for Fiscal 2024, Ended June 30, 2024 (PR Newswire) -8.93%
Aug-05-24 04:05PM	Azenta to Participate in 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference (PR Newswire)
Jul-24-24 04:05PM	Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and Webcast (PR Newswire)
Jul-22-24 04:05PM	FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study (PR Newswire) +8.10%
Jun-04-24 04:05PM	Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research (PR Newswire)
May-23-24 04:05PM	Azenta to Participate in the Jefferies Global Healthcare Conference (PR Newswire)
May-14-24 06:34AM	Stock Market Crash Warning: Don't Get Caught Holding These 3 Robotics Stocks (InvestorPlace)
May-13-24 04:46PM	Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK (PR Newswire)
May-10-24 01:07PM	Azenta Inc (AZTA) Q2 Fiscal 2024 Earnings: Revenue Growth Amid Challenges (GuruFocus.com)
May-09-24 12:53PM	Azenta, Inc. (NASDAQ:AZTA) Q2 2024 Earnings Call Transcript (Insider Monkey)
May-08-24 08:58PM	AZTA Stock Earnings: Azenta Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace)

Azenta, Inc. is a global provider of life sciences solutions, enabling organizations worldwide to bring impactful breakthroughs and therapies to market faster. The company offers a suite of reliable cold-chain sample management solutions and multiomics services supporting drug development, clinical research, and advanced cell therapies for pharmaceutical, biotechnology, academic, and healthcare institutions globally. It operates through the following segments: Sample Management Solutions and Multiomics. The Sample Management Solutions segment provides end-to-end sample management products and services, including Sample Repository Services (SRS). Its core products include automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled-rate thawing devices. The Multiomics segment delivers genomic and other sample analysis services, including gene sequencing, gene synthesis, and related services. The company was founded in 1978 and is headquartered in Burlington, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Marotta John	President and CEO	Sep 10 '25	Sale	29.41	316	9,294	105,980	Sep 12 04:10 PM
Lin Lawrence Y.	EVP, CFO and Treasurer	Aug 11 '25	Buy	27.96	2,500	69,900	46,013	Aug 12 04:05 PM

Open in Screener

RGEN

Repligen Corp

Feb 13 • 04:00PM ET

136.44

+3.81 2.87 %

Healthcare • Medical Instruments & Supplies • USA • NASD

Peers: BIO TMO DHR WAT ILMN BRKR TECH MTD QGEN A

| Held by: VTI IJH VB VBK VXF FBT IBB MDY SPMD IWR

Index	-	P/E	5308.95	EPS (ttm)	0.03	Insider Own	5.46%	Shs Outstand	56.28M	Perf Week	-4.04%
Market Cap	7.68B	Forward P/E	65.69	EPS next Y	2.08	Insider Trans	-2.65%	Shs Float	53.22M	Perf Month	-15.79%
Enterprise Value	7.62B	PEG	3.47	EPS next Q	0.44	Inst Own	112.71%	Short Float	7.62%	Perf Quarter	-13.65%
Income	1.74M	P/S	10.85	EPS this Y	5.32%	Inst Trans	10.56%	Short Ratio	5.89	Perf Half Y	7.74%
Sales	707.89M	P/B	3.69	EPS next Y	24.81%	ROA	0.06%	Short Interest	4.05M	Perf YTD	-16.73%
Book/sh	37.01	P/C	10.26	EPS next 5Y	18.91%	ROE	0.08%	52W High	175.77 -22.38%	Perf Year	-6.66%
Cash/sh	13.30	P/FCF	72.13	EPS past 3/5Y	- -	ROIC	0.06%	52W Low	102.96 32.51%	Perf 3Y	-27.48%
Dividend Est.	-	EV/EBITDA	44.59	Sales past 3/5Y	-1.83% 18.61%	Gross Margin	46.80%	Volatility	5.36% 4.86%	Perf 5Y	-39.70%
Dividend TTM	-	EV/Sales	10.76	EPS Y/Y TTM	120.01%	Oper. Margin	6.60%	ATR (14)	7.24	Perf 10Y	493.99%
Dividend Ex-Date	-	Quick Ratio	7.14	Sales Y/Y TTM	11.74%	Profit Margin	0.25%	RSI (14)	31.20	Recom	1.52
Dividend Gr. 3/5Y	- -	Current Ratio	8.36	EPS Q/Q	2354.70%	SMA20	-10.32%	Beta	1.15	Target Price	191.67
Payout	-	Debt/Eq	0.33	Sales Q/Q	21.91%	SMA50	-14.38%	Rel Volume	1.11	Prev Close	132.63
Employees	1778	LT Debt/Eq	0.32	Earnings	Feb 24 BMO	SMA200	-1.90%	Avg Volume	688.59K	Price	136.44
IPO	Apr 29, 1986	Option/Short	Yes / Yes	EPS/Sales Surpr.	9.11% 3.64%	Trades		Volume	766,999	Change	2.87%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-01-25	Initiated	HSBC Securities	Buy	$150
Sep-22-25	Upgrade	Evercore ISI	In-line → Outperform	$155
Jul-22-25	Resumed	Stephens	Overweight	$160
Jun-24-25	Initiated	Barclays	Overweight	$150
Apr-29-25	Upgrade	Wolfe Research	Peer Perform → Outperform	$160
Mar-18-25	Initiated	Evercore ISI	In-line	$155
Feb-10-25	Initiated	TD Cowen	Buy	$200
Dec-17-24	Initiated	Canaccord Genuity	Hold	$165
Nov-14-24	Initiated	Wolfe Research	Peer Perform
Aug-28-24	Initiated	Wells Fargo	Overweight	$180
Jun-26-24	Upgrade	Deutsche Bank	Hold → Buy	$180 → $155
Jun-18-24	Initiated	Guggenheim	Neutral
Dec-04-23	Downgrade	The Benchmark Company	Buy → Hold
Jul-20-23	Initiated	Wells Fargo	Overweight	$185
Jul-05-23	Resumed	JP Morgan	Overweight	$220
Mar-28-23	Initiated	The Benchmark Company	Buy	$230
Dec-14-22	Initiated	Deutsche Bank	Hold	$180
Dec-07-22	Initiated	RBC Capital Mkts	Sector Perform	$190
Jul-20-22	Initiated	UBS	Buy	$213
Oct-14-21	Initiated	Exane BNP Paribas	Outperform	$330

Show Previous Ratings

Feb-10-26 07:30AM	Repligen to Report Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Feb-06-26 08:16AM	What Makes Repligen Corporation (RGEN) an Investment Choice? (Insider Monkey)
Feb-04-26 08:04PM	Analyst Report: Repligen Corporation (Morningstar Research)
Jan-26-26 11:01PM	3 Reasons to Sell RGEN and 1 Stock to Buy Instead (StockStory)
Jan-22-26 09:52PM	UBS Tags Repligen (RGEN) as Bioprocessing Leader for 2026, Cites 20% Order Growth and Reshoring Tailwinds (Insider Monkey)
02:15PM	Loading…
Jan-14-26 02:15PM	Why Repligen (RGEN) Shares Are Sliding Today (StockStory)
Jan-06-26 07:30AM	Repligen Executive Chair Tony Hunt to Retire; Dr. Martin D. Madaus Elected Chair (GlobeNewswire)
Dec-18-25 07:30AM	Repligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference (GlobeNewswire)
Dec-17-25 08:35AM	Here's Why Sands Capital Global Growth Fund Decided to Sell Repligen Corporation (RGEN) (Insider Monkey)
Dec-16-25 07:30AM	Repligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows (GlobeNewswire)
Dec-07-25 11:35PM	1 Volatile Stock to Target This Week and 2 We Turn Down (StockStory)
Dec-03-25 11:30AM	Why Is Exact Sciences (EXAS) Up 45.4% Since Last Earnings Report? (Zacks)
Nov-26-25 07:30AM	Repligen Corporation to Present at Evercore Healthcare Conference (GlobeNewswire)
Nov-21-25 07:09PM	Analyst Report: Repligen Corporation (Morningstar Research) +5.28%
06:36PM	Why Repligen (RGEN) Stock Is Trading Up Today (StockStory)
10:31PM	Loading…
Nov-06-25 10:31PM	Drug Development Inputs & Services Stocks Q3 Recap: Benchmarking Repligen (NASDAQ:RGEN) (StockStory)
Nov-04-25 07:30AM	Repligen Corporation to Present at Upcoming November Conferences (GlobeNewswire)
12:32AM	5 Revealing Analyst Questions From Repligen's Q3 Earnings Call (StockStory)
Oct-30-25 07:45PM	Analyst Report: Repligen Corporation (Morningstar Research)
Oct-29-25 01:13PM	Analyst Report: Repligen Corporation (Morningstar Research)
11:18AM	RGEN'S Q3 Earnings Beat Estimates, Revenues Surge Y/Y, Stock Down (Zacks)
09:40AM	RGEN Q3 Deep Dive: Robust Product Demand Offset by Margin Pressures and Guidance Reset (StockStory)
Oct-28-25 02:35PM	Why Repligen (RGEN) Shares Are Trading Lower Today (StockStory) -5.92%
08:45AM	Repligen (RGEN) Q3 Earnings and Revenues Surpass Estimates (Zacks)
08:01AM	Repligen's (NASDAQ:RGEN) Q3 Sales Beat Estimates (StockStory)
07:40AM	Repligen: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance (GlobeNewswire)
Oct-27-25 09:22AM	Earnings To Watch: Repligen Corp (RGEN) Reports Q3 2025 Result (GuruFocus.com)
Oct-26-25 11:13PM	Repligen Earnings: What To Look For From RGEN (StockStory)
Oct-23-25 07:15PM	Analyst Report: Repligen Corporation (Morningstar Research)
10:00AM	Loading…
10:00AM	Apellis Pharmaceuticals, Inc. (APLS) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Oct-21-25 11:40AM	ALKS vs. RGEN: Which Stock Is the Better Value Option? (Zacks)
10:00AM	Earnings Preview: Repligen (RGEN) Q3 Earnings Expected to Decline (Zacks)
Oct-15-25 07:30AM	Repligen to Report Third Quarter 2025 Financial Results (GlobeNewswire)
Oct-09-25 07:46AM	Is Repligen (RGEN) The Best Healthcare Stock to Buy Now? (Insider Monkey)
Oct-01-25 12:20PM	Why Is Repligen (RGEN) Stock Soaring Today (StockStory) +9.08%
Sep-30-25 04:05PM	Repligen, BrightSpring Health Services, Danaher, Thermo Fisher, and Amgen Shares Skyrocket, What You Need To Know (StockStory) +7.72%
Sep-24-25 12:04AM	3 Reasons to Sell RGEN and 1 Stock to Buy Instead (StockStory)
Sep-22-25 11:31PM	Drug Development Inputs & Services Stocks Q2 Results: Benchmarking Repligen (NASDAQ:RGEN) (StockStory)
Sep-16-25 02:51PM	Repligen (RGEN) Stock Is Up, What You Need To Know (StockStory) +5.28%
Sep-12-25 02:26PM	Why Repligen (RGEN) Stock Is Down Today (StockStory)
Aug-22-25 03:40PM	Repligen, Revvity, Avantor, Fortrea, and Azenta Shares Skyrocket, What You Need To Know (StockStory)
07:30AM	Repligen Corporation to Present at Upcoming September Conferences (GlobeNewswire)
Aug-20-25 08:42AM	Do Options Traders Know Something About Repligen Stock We Don't? (Zacks)
Aug-12-25 12:53AM	RGEN Q2 Deep Dive: Chromatography and Filtration Drive Growth, Guidance Lifted Amid New Modalities Uncertainty (StockStory) +8.51%
12:35AM	5 Must-Read Analyst Questions From Repligen's Q2 Earnings Call (StockStory)
Aug-07-25 09:45AM	Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Jul-31-25 07:30AM	Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalization (GlobeNewswire)
Jul-29-25 11:52PM	Analyst Report: Repligen Corporation (Morningstar Research)
02:26PM	Why Repligen (RGEN) Stock Is Up Today (StockStory)
08:45AM	Repligen (RGEN) Lags Q2 Earnings Estimates (Zacks)
08:09AM	Repligen's (NASDAQ:RGEN) Q2 Sales Top Estimates, Full-Year Sales Guidance is Optimistic (StockStory)
07:41AM	Repligen: Q2 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance (GlobeNewswire)
Jul-28-25 09:22AM	Repligen Corp (RGEN) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Jul-27-25 11:06PM	Repligen (RGEN) Reports Q2: Everything You Need To Know Ahead Of Earnings (StockStory)
Jul-22-25 09:40AM	Netflix downgraded, Intel initiated: Wall Street's top analyst calls (The Fly)
Jul-21-25 09:45AM	Here's Why Repligen (RGEN) is a Strong Growth Stock (Zacks)
Jul-18-25 03:11PM	Repligen, Bruker, Fortrea, Azenta, and Biogen Stocks Trade Down, What You Need To Know (StockStory) -6.28%
12:03AM	3 Reasons RGEN is Risky and 1 Stock to Buy Instead (StockStory)
Jul-17-25 07:30AM	Repligen to Report Second Quarter 2025 Financial Results (GlobeNewswire)
Jun-24-25 02:18PM	5 Insightful Analyst Questions From Repligen's Q1 Earnings Call (StockStory)
Jun-16-25 08:00AM	908 Devices Appoints Christopher D. Brown to its Board of Directors (Business Wire)
Jun-04-25 11:36PM	Winners And Losers Of Q1: Repligen (NASDAQ:RGEN) Vs The Rest Of The Drug Development Inputs & Services Stocks (StockStory)
Jun-03-25 11:32PM	Drug Development Inputs & Services Stocks Q1 In Review: Repligen (NASDAQ:RGEN) Vs Peers (StockStory)
Jun-02-25 01:36PM	Do Options Traders Know Something About Repligen (RGEN) Stock We Don't? (Zacks)
May-29-25 11:30AM	Why Is Repligen (RGEN) Down 12.2% Since Last Earnings Report? (Zacks)
May-27-25 07:30AM	Repligen Announces Publication of the Company's 2024 Corporate Sustainability Report (GlobeNewswire)
May-22-25 07:30AM	Repligen Corporation to Present at William Blair Growth Conference (GlobeNewswire)
May-09-25 12:36AM	1 High-Flying Stock with Exciting Potential and 2 to Keep Off Your Radar (StockStory)
May-07-25 07:30AM	Repligen Corporation to Present at Upcoming May Investor Conferences (GlobeNewswire)
May-02-25 11:40AM	QGEN or RGEN: Which Is the Better Value Stock Right Now? (Zacks)
08:18AM	Repligen Corp. (RGEN) Slid On Uncertainty Related To U.S. Federal Government Spending On Healthcare (Insider Monkey)
May-01-25 12:11PM	Jim Cramer on Repligen Corporation (RGEN): 'I'm Not Quite Ready to Stick My Neck Out on This One' (Insider Monkey)
Apr-30-25 04:19PM	RGEN Q1 Earnings Call: Repligen Delivers Above-Consensus Revenue, Raises Sales Outlook Amid Tariff Uncertainty (StockStory)
10:55AM	Analyst Report: Repligen Corporation (Morningstar Research)
09:07AM	Repligen's Q1 Earnings Beat Estimates, Revenues Surge Y/Y (Zacks)
03:09AM	Repligen Corp (RGEN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Apr-29-25 11:50PM	Q1 2025 Repligen Corp Earnings Call (Thomson Reuters StreetEvents)
12:58PM	Repligen Corporation (RGEN) Q1 2025 Earnings Call Transcript (Seeking Alpha)
08:45AM	Repligen (RGEN) Tops Q1 Earnings and Revenue Estimates (Zacks)
08:05AM	Repligen (NASDAQ:RGEN) Posts Better-Than-Expected Sales In Q1, Full-Year Outlook Slightly Exceeds Expectations (StockStory)
07:45AM	Repligen: Q1 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports First Quarter 2025 Financial Results (GlobeNewswire)
Apr-28-25 07:08PM	What To Expect From Repligen Corp (RGEN) Q1 2025 Earnings (GuruFocus.com)
03:08AM	Repligen (RGEN) Q1 Earnings: What To Expect (StockStory)
Apr-25-25 09:16AM	3 Healthcare Stocks That Concern Us (StockStory)
Apr-23-25 12:10PM	Will Repligen (RGEN) Beat Estimates Again in Its Next Earnings Report? (Zacks)
10:01AM	Earnings Preview: Guardant Health (GH) Q1 Earnings Expected to Decline (Zacks)
Apr-22-25 10:01AM	Repligen (RGEN) Reports Next Week: Wall Street Expects Earnings Growth (Zacks) +5.54%
Apr-16-25 11:40AM	GMAB or RGEN: Which Is the Better Value Stock Right Now? (Zacks)
Apr-15-25 07:30AM	Repligen to Report First Quarter 2025 Financial Results (GlobeNewswire)
Apr-10-25 05:03AM	Repligen (RGEN): Buy, Sell, or Hold Post Q4 Earnings? (StockStory) -6.99%
Apr-08-25 07:30AM	Repligen Appoints Jacob Johnson As Vice President Investor Relations (GlobeNewswire) -6.22%
04:11AM	Repligen (RGEN) Moves 3.7% Higher: Will This Strength Last? (Zacks)
Mar-28-25 01:38PM	Baird Q4 2024 Mid Cap Growth Strategy Commentary (Seeking Alpha)
Mar-25-25 12:46PM	Is Repligen Corporation (RGEN) the Top Stock to Buy According to 12 West Capital Management? (Insider Monkey)
Mar-20-25 07:52AM	Repligen: Ongoing Bioprocessing Market Recovery (SeekingAlpha)
Mar-17-25 05:09AM	Q4 Rundown: PacBio (NASDAQ:PACB) Vs Other Life Sciences Tools & Services Stocks (StockStory)
Mar-12-25 05:01AM	Q4 Earnings Recap: Azenta (NASDAQ:AZTA) Tops Drug Development Inputs & Services Stocks (StockStory)

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DAWES KAREN A	Director	Dec 17 '25	Sale	161.00	275	44,275	91,821	Dec 18 04:30 PM
MUIR GLENN P	Director	Dec 16 '25	Option Exercise	26.12	3,366	87,920	36,622	Dec 17 04:30 PM
DAWES KAREN A	Director	Dec 17 '25	Proposed Sale	161.00	275	44,275		Dec 17 04:28 PM
Loeillot Olivier	Chief Executive Officer	Nov 25 '25	Sale	170.00	7,041	1,196,970	35,898	Nov 26 04:30 PM
Loeillot Olivier	Officer	Nov 25 '25	Proposed Sale	170.00	7,041	1,196,970		Nov 25 12:06 PM
Bylund James	Chief Operating Officer	Nov 18 '25	Sale	151.21	2,191	331,301	21,520	Nov 19 04:30 PM
Bylund James	Officer	Nov 18 '25	Proposed Sale	151.21	2,191	331,304		Nov 18 04:10 PM
Hunt Anthony	Director	Nov 13 '25	Option Exercise	33.87	2,952	99,984	83,695	Nov 14 04:30 PM
Hunt Anthony	Director	Nov 13 '25	Sale	154.61	20,000	3,092,278	80,743	Nov 14 04:30 PM
Hunt Anthony	Director	Nov 12 '25	Option Exercise	33.87	25,000	846,750	125,743	Nov 13 04:30 PM
Hunt Anthony	Director	Nov 12 '25	Sale	156.88	25,000	3,921,940	100,743	Nov 13 04:30 PM
Hunt Anthony	Director	Nov 13 '25	Proposed Sale	154.62	20,000	3,092,327		Nov 13 04:11 PM
Hunt Anthony	Director	Nov 12 '25	Proposed Sale	156.88	25,000	3,921,981		Nov 12 04:37 PM
Hunt Anthony	Director	Sep 10 '25	Option Exercise	33.87	20,000	677,400	129,854	Sep 11 02:55 PM
Hunt Anthony	Director	Sep 10 '25	Sale	120.52	29,111	3,508,389	100,743	Sep 11 02:55 PM
Hunt Anthony	Director	Sep 10 '25	Proposed Sale	120.52	29,111	3,508,378		Sep 10 04:22 PM
Madaus Martin D	Director	Aug 08 '25	Buy	112.13	1,800	201,830	1,800	Aug 12 12:47 PM
Hunt Anthony	Director	May 15 '25	Sale	123.71	26,447	3,271,688	109,854	May 16 03:02 PM
Hunt Anthony	Director	May 15 '25	Proposed Sale	128.34	26,447	3,394,208		May 15 10:25 AM
Hunt Anthony	Director	Mar 17 '25	Option Exercise	54.73	26,756	1,464,267	163,057	Mar 19 04:21 PM
Hunt Anthony	Director	Mar 17 '25	Sale	152.51	26,756	4,080,663	136,301	Mar 19 04:21 PM
Pax Margaret	Director	Mar 17 '25	Buy	150.69	250	37,672	1,043	Mar 18 03:58 PM
Hunt Anthony	Director	Mar 17 '25	Proposed Sale	150.42	26,756	4,024,638		Mar 17 10:04 AM

HOLX

Hologic, Inc

AZTA

Azenta Inc

RGEN

Repligen Corp

Upgrade your FINVIZ experience